These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 23525242)

  • 1. KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells.
    Cvetkovic D; Dragan M; Leith SJ; Mir ZM; Leong HS; Pampillo M; Lewis JD; Babwah AV; Bhattacharya M
    Endocrinology; 2013 Jun; 154(6):1999-2014. PubMed ID: 23525242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KISS1R signaling promotes invadopodia formation in human breast cancer cell via β-arrestin2/ERK.
    Goertzen CG; Dragan M; Turley E; Babwah AV; Bhattacharya M
    Cell Signal; 2016 Mar; 28(3):165-176. PubMed ID: 26721186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPR54 (KISS1R) transactivates EGFR to promote breast cancer cell invasiveness.
    Zajac M; Law J; Cvetkovic DD; Pampillo M; McColl L; Pape C; Di Guglielmo GM; Postovit LM; Babwah AV; Bhattacharya M
    PLoS One; 2011; 6(6):e21599. PubMed ID: 21738726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of KiSS1 and KiSS1R expression in human primary breast cancer: Association with breast cancer receptor status, proliferation markers and clinicopathological features.
    Jarzabek K; Koda M; Kozlowski L; Milewski R; Wolczynski S
    Histol Histopathol; 2015 Jun; 30(6):715-23. PubMed ID: 25535062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
    Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
    Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
    Travaglini L; Vian L; Billi M; Grignani F; Nervi C
    Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.
    Alemayehu M; Dragan M; Pape C; Siddiqui I; Sacks DB; Di Guglielmo GM; Babwah AV; Bhattacharya M
    PLoS One; 2013; 8(2):e56174. PubMed ID: 23405264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of TBK1 induces epithelial-mesenchymal transition in the breast cancer cells by ERα downregulation.
    Yang KM; Jung Y; Lee JM; Kim W; Cho JK; Jeong J; Kim SJ
    Cancer Res; 2013 Nov; 73(22):6679-89. PubMed ID: 24062311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
    Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KISS1/KISS1R and Breast Cancer: Metastasis Promoter.
    Guzman S; Brackstone M; Wondisford F; Babwah AV; Bhattacharya M
    Semin Reprod Med; 2019 Jul; 37(4):197-206. PubMed ID: 31972865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kisspeptin-10 inhibits the migration of breast cancer cells by regulating epithelial-mesenchymal transition.
    Song GQ; Zhao Y
    Oncol Rep; 2015 Feb; 33(2):669-74. PubMed ID: 25420482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
    Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
    Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
    Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
    Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O; Lattrich C; Springwald A; Ortmann O
    Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KISS1 is down-regulated by 17beta-estradiol in MDA-MB-231 cells through a nonclassical mechanism and loss of ribonucleic acid polymerase II binding at the proximal promoter.
    Huijbregts L; de Roux N
    Endocrinology; 2010 Aug; 151(8):3764-72. PubMed ID: 20534720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.
    Duss S; André S; Nicoulaz AL; Fiche M; Bonnefoi H; Brisken C; Iggo RD
    Breast Cancer Res; 2007; 9(3):R38. PubMed ID: 17573968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells.
    Sisci D; Middea E; Morelli C; Lanzino M; Aquila S; Rizza P; Catalano S; Casaburi I; Maggiolini M; Andò S
    Breast Cancer Res Treat; 2010 Nov; 124(1):63-77. PubMed ID: 20052536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.